Literature DB >> 25085957

Psoriasis.

Paola Di Meglio1, Federica Villanova2, Frank O Nestle2.   

Abstract

Psoriasis is a common chronic inflammatory skin disease with a spectrum of clinical phenotypes and results from the interplay of genetic, environmental, and immunological factors. Four decades of clinical and basic research on psoriasis have elucidated many of the pathogenic mechanisms underlying disease and paved the way to effective targeted therapies. Here, we review this progress and identify future directions of study that are supported by a more integrative research approach and aim at further improving the patients' life.
Copyright © 2014 Cold Spring Harbor Laboratory Press; all rights reserved.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25085957      PMCID: PMC4109580          DOI: 10.1101/cshperspect.a015354

Source DB:  PubMed          Journal:  Cold Spring Harb Perspect Med        ISSN: 2157-1422            Impact factor:   6.915


  226 in total

1.  Psoriasis triggered by toll-like receptor 7 agonist imiquimod in the presence of dermal plasmacytoid dendritic cell precursors.

Authors:  Michel Gilliet; Curdin Conrad; Michael Geiges; Antonio Cozzio; Wolfgang Thürlimann; Günter Burg; Frank O Nestle; Reinhard Dummer
Journal:  Arch Dermatol       Date:  2004-12

2.  Double-blind, placebo-controlled, dose-escalation study to evaluate the pharmacologic effect of CP-690,550 in patients with psoriasis.

Authors:  Mary G Boy; Cunshan Wang; Bethanie E Wilkinson; Vincent Fung-Sing Chow; Alan T Clucas; James G Krueger; Anderson S Gaweco; Samuel H Zwillich; Paul S Changelian; Gary Chan
Journal:  J Invest Dermatol       Date:  2009-02-19       Impact factor: 8.551

3.  Subpopulations of mononuclear cells in microscopic lesions of psoriatic patients. Selective accumulation of suppressor/cytotoxic T cells in epidermis during the evolution of the lesion.

Authors:  H Hammar; S Q Gu; A Johannesson; K G Sundkvist; P Biberfeld
Journal:  J Invest Dermatol       Date:  1984-12       Impact factor: 8.551

4.  An Italian study on psoriasis and depression.

Authors:  Maria Esposito; Rosita Saraceno; Alessandro Giunta; Mara Maccarone; Sergio Chimenti
Journal:  Dermatology       Date:  2006       Impact factor: 5.366

5.  Psoriasis in Australian twins.

Authors:  D L Duffy; L S Spelman; N G Martin
Journal:  J Am Acad Dermatol       Date:  1993-09       Impact factor: 11.527

6.  Long-term safety of ustekinumab in patients with moderate-to-severe psoriasis: final results from 5 years of follow-up.

Authors:  K A Papp; C E M Griffiths; K Gordon; M Lebwohl; P O Szapary; Y Wasfi; D Chan; M-C Hsu; V Ho; P D Ghislain; B Strober; K Reich
Journal:  Br J Dermatol       Date:  2013-04       Impact factor: 9.302

7.  Expanding the psoriasis disease profile: interrogation of the skin and serum of patients with moderate-to-severe psoriasis.

Authors:  Mayte Suárez-Fariñas; Katherine Li; Judilyn Fuentes-Duculan; Karen Hayden; Carrie Brodmerkel; James G Krueger
Journal:  J Invest Dermatol       Date:  2012-07-05       Impact factor: 8.551

8.  Genome-wide expression profiling of five mouse models identifies similarities and differences with human psoriasis.

Authors:  William R Swindell; Andrew Johnston; Steve Carbajal; Gangwen Han; Christian Wohn; Jun Lu; Xianying Xing; Rajan P Nair; John J Voorhees; James T Elder; Xiao-Jing Wang; Shigetoshi Sano; Errol P Prens; John DiGiovanni; Mark R Pittelkow; Nicole L Ward; Johann E Gudjonsson
Journal:  PLoS One       Date:  2011-04-04       Impact factor: 3.240

9.  Spontaneous development of psoriasis in a new animal model shows an essential role for resident T cells and tumor necrosis factor-alpha.

Authors:  Onur Boyman; Hans Peter Hefti; Curdin Conrad; Brian J Nickoloff; Mark Suter; Frank O Nestle
Journal:  J Exp Med       Date:  2004-02-23       Impact factor: 14.307

10.  IL-23 stimulates epidermal hyperplasia via TNF and IL-20R2-dependent mechanisms with implications for psoriasis pathogenesis.

Authors:  Jason R Chan; Wendy Blumenschein; Erin Murphy; Caroline Diveu; Maria Wiekowski; Susan Abbondanzo; Linda Lucian; Richard Geissler; Scott Brodie; Alexa B Kimball; Daniel M Gorman; Kathleen Smith; Rene de Waal Malefyt; Robert A Kastelein; Terrill K McClanahan; Edward P Bowman
Journal:  J Exp Med       Date:  2006-10-30       Impact factor: 14.307

View more
  76 in total

Review 1.  Crosstalk between the nociceptive and immune systems in host defence and disease.

Authors:  Stephen B McMahon; Federica La Russa; David L H Bennett
Journal:  Nat Rev Neurosci       Date:  2015-07       Impact factor: 34.870

Review 2.  IL-12 and IL-23 cytokines: from discovery to targeted therapies for immune-mediated inflammatory diseases.

Authors:  Michele W L Teng; Edward P Bowman; Joshua J McElwee; Mark J Smyth; Jean-Laurent Casanova; Andrea M Cooper; Daniel J Cua
Journal:  Nat Med       Date:  2015-06-29       Impact factor: 53.440

3.  Modelling epidermis homoeostasis and psoriasis pathogenesis.

Authors:  Hong Zhang; Wenhong Hou; Laurence Henrot; Sylvianne Schnebert; Marc Dumas; Catherine Heusèle; Jin Yang
Journal:  J R Soc Interface       Date:  2015-02-06       Impact factor: 4.118

Review 4.  Calcitonin gene-related peptide: key regulator of cutaneous immunity.

Authors:  R D Granstein; J A Wagner; L L Stohl; W Ding
Journal:  Acta Physiol (Oxf)       Date:  2015-01-05       Impact factor: 6.311

Review 5.  The Role of IL-17 in the Pathogenesis and Treatment of Psoriasis.

Authors:  Joshua A Zeichner; April Armstrong
Journal:  J Clin Aesthet Dermatol       Date:  2016-06-01

Review 6.  Molecular mechanisms of mechanotransduction in psoriasis.

Authors:  Lina S Malakou; Antonios N Gargalionis; Christina Piperi; Evangelia Papadavid; Athanasios G Papavassiliou; Efthimia K Basdra
Journal:  Ann Transl Med       Date:  2018-06

7.  The Presence of HLA-A Bw4-80I KIR Ligands Could Predict "Difficult-to-Treat" Psoriasis and Poor Response to Etanercept.

Authors:  M Guarene; A Pasi; V Bolcato; R Cananzi; A Piccolo; I Sbarsi; C Klersy; R Cacciatore; Valeria Brazzelli
Journal:  Mol Diagn Ther       Date:  2018-08       Impact factor: 4.074

Review 8.  The influence of skin microorganisms on cutaneous immunity.

Authors:  Yasmine Belkaid; Samira Tamoutounour
Journal:  Nat Rev Immunol       Date:  2016-05-27       Impact factor: 53.106

9.  Chronic Psoriatic Skin Inflammation Leads to Increased Monocyte Adhesion and Aggregation.

Authors:  Jackelyn B Golden; Sarah G Groft; Michael V Squeri; Sara M Debanne; Nicole L Ward; Thomas S McCormick; Kevin D Cooper
Journal:  J Immunol       Date:  2015-07-29       Impact factor: 5.422

Review 10.  The Inflammatory Response in Psoriasis: a Comprehensive Review.

Authors:  Yaxiong Deng; Christopher Chang; Qianjin Lu
Journal:  Clin Rev Allergy Immunol       Date:  2016-06       Impact factor: 8.667

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.